News

Filter

Current filters:

BiotechnologyLicensing

226 to 235 of 97511 results

Daiichi Sankyo gets Japanese approval for Methylene Blue

05-01-2015

Japanese drug major Daiichi Sankyo has received approval in Japan for the manufacture and marketing of…

Daiichi SankyoHematologyJapanMethylene Blue InjectionPharmaceuticalProvepharmRegulation

Eisai's Fycompa for refractory partial-onset seizures meets Phase III trial primary endpoint

Eisai's Fycompa for refractory partial-onset seizures meets Phase III trial primary endpoint

05-01-2015

Japanese drug major Eisai has announced a Phase III trial of antiepileptic drug Fycompa (perampanel)…

EisaiFycompaJapanNeurologicalperampanelPharmaceuticalResearch

Cempra announces positive results from Phase III trial of solithromycin in bacterial pneumonia

Cempra announces positive results from Phase III trial of solithromycin in bacterial pneumonia

05-01-2015

Antibiotic specialist Cempra has announced positive top-line results from its pivotal Phase III trial…

Antibiotics and Infectious diseasesBiotechnologyCempraResearchsolithromycinUSA

EXPERT VIEW: Strengthening market access through insight-driven real-world evidence

EXPERT VIEW: Strengthening market access through insight-driven real-world evidence

05-01-2015

Growing demand for access to health care alongside advances in science and technology has led to heightened…

EnbrelGlobalPharmaceuticalRegulationSenior Consulting

IN FOCUS: Nanobiotix CEO Laurent Levy explains the many benefits of nanomedicine

IN FOCUS: Nanobiotix CEO Laurent Levy explains the many benefits of nanomedicine

05-01-2015

Nanotechnology is poised to become the ‘next big thing’ in global health care. While big pharma companies…

FranceNanobiotixOncologyPharmaceuticalResearch

Walgreens and Alliance Boots complete Step 2 of merger

Walgreens and Alliance Boots complete Step 2 of merger

04-01-2015

USA-headquartered Walgreen and Europe’s Alliance Boots GmbH on January 1 completed Step 2 of their…

Alliance BootsEuropeMergers & AcquisitionsPharmaceuticalUSAWalgreensWalgreens Boots Alliance

TxCell and Ferring collaborate with Trizell on lead product Ovasave

TxCell and Ferring collaborate with Trizell on lead product Ovasave

04-01-2015

French biotech firm TxCell on Friday announced a further enhancement to the development of its lead product…

BiotechnologyFerring PharmaceuticalsGastro-intestinalsLicensingOvaSaveResearchTrizell HoldingTxCell

In 2014, FDA approved highest number of new drugs in 18 years

In 2014, FDA approved highest number of new drugs in 18 years

04-01-2015

The US Food and Drug Administration's Center for Drug Evaluation and Research approved 41 novel medicines…

AstraZenecaGilead SciencesPharmaceuticalRegulationUSA

Echo Therapeutics appoints Alan Schoenbart as chief financial officer

Echo Therapeutics appoints Alan Schoenbart as chief financial officer

02-01-2015

Medical device company Echo Therapeutics has appointed Alan Schoenbart as chief financial officer.

Alan SchoenbartBoardroomDollhouseEcho TherapeuticsPharmaceutical

226 to 235 of 97511 results

Back to top